Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the growing popularity of compounded alternatives have raised critical questions ...

There are no head-to-head trials comparing these three approaches, said Vanita Rahman, MD, clinic director of the Barnard ...

Deciding when it's time for senior living can be challenging. However, a senior living community can be a positive step.

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...